Health Condition 1: M849- Disorder of continuity of bone, unspecified
Conditions
Interventions
Intervention1: Allogenic Wharton Jelly derived Stem cells: Patients undergoing hip arthroplasty either Total Hip Arthroplasty or Bipolar Arthroplasty for Fracture neck of femur with posterior approach
Sponsors
RESEARCH SECTION ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Eligibility
Inclusion criteria
Inclusion criteria: NA
Exclusion criteria
Exclusion criteria: NA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Short Physical Performance Battery (sPPB) at week 26 after injection serves as the primary end- point for evaluating efficacy.Timepoint: The Short Physical Performance Battery (sPPB) at week 26 after injection serves as the primary end- point for evaluating efficacy. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare Lower Extremities Measure (LEM) and assessment of abduction strength in all the three groups at the end of 26 weeks and 52 weeks and cause of mortality if any at the end of 1 year.Timepoint: 26 weeks and 52 weeks | — |
Countries
India
Contacts
Public ContactDR. SAHIL BATRA
ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Outcome results
None listed